Transforming asthma care: improving patient and environmental outcomes (Promotional content from AstraZeneca) | GPnotebook TV

This site is intended for UK healthcare professionals

This promotional video has been initiated, created, funded and reviewed by AstraZeneca. This promotional video page is intended for UK Healthcare Professionals only and AstraZeneca products will be discussed. The content has been reviewed and approved by the sponsoring company AstraZeneca and the speakers. Editorial support for this video has been provided by OmniaMed Communications. GPnotebook has had no input into the content.


Please note: Symbicort (budesonide/formoterol) Turbohaler 100/6, 200/6 are licensed for Maintenance And Reliever Therapy (MART)1,2

Symbicort Turbohaler 400/12 is licensed for Maintenance Therapy only3

Transforming asthma care: improving patient and environmental outcomes (Promotional content from AstraZeneca)

17 August 2022


A plethora of national and international guidelines exist for the management of asthma; how can healthcare professionals best make sense of these different sources of advice, in order to develop a management plan that best suits the needs of the patient in front of them? Not only must the patient’s individual clinical characteristics, preferences and lifestyle factors be taken into consideration, but also national clinical priorities such as the NHS sustainability agenda. This video offers an evidence-based approach to individualising asthma management.

Symbicort Turbohaler licensed indication

Symbicort® Turbohaler is indicated for adults, adolescents 12 years and older and children aged 6 years and older (100/6 Turbohaler for maintenance therapy only) for the regular treatment of asthma where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonists) is appropriate:

– Patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists

– Patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists

Symbicort Turbohaler 400/12 should be used as Maintenance Therapy only. Lower strengths are available for the Symbicort Maintenance and Reliever Therapy regimen (100mcg/6mcg/inhalation Turbohaler, 200mcg/6mcg/inhalation Turbohaler).


  1. SYMBICORT (budesonide/formoterol) Turbohaler 100/6, Inhalation powder. Summary of Product Characteristics  
  2. SYMBICORT (budesonide/formoterol) Turbohaler 200/6, Inhalation powder. Summary of Product Characteristics  
  3. SYMBICORT (budesonide/formoterol) Turbohaler 400/12, Inhalation powder. Summary of Product Characteristics

Adverse events should be reported. Reporting forms and information can be found at or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to AstraZeneca by visiting or by calling 0800 783 0033.

GB-38224 | August 2022

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.

To continue, please confirm that you are a UK healthcare professional.

This account does not have a GPnotebook Pro registration

You need to register for GPnotebook Pro in order to track your activity on GPnotebook TV


You’re now logged in, and the time you spend watching GPnotebook TV episodes will be tracked in your GPnotebook Pro CPD dashboard.

When the time is right, you can visit the dashboard to add reflective notes and claim CPD credits

Log in to track your activity and claim CPD credits

  • If you have registered for GPnotebook Pro, you can now automatically track the videos you watch on GPnotebook TV for CPD purposes
  • Simply log in to GPnotebook TV before watching any videos and your activity will be logged in your GPnotebook Pro dashboard
  • When the time is right, visit your GPnotebook Pro CPD dashboard to add reflections and claim CPD credits
  • A GPnotebook Pro account also provides access to exclusive videos 

Already registered for GPnotebook Pro?

Not yet registered for GPnotebook Pro?

GPnotebook Pro is currently available to UK healthcare professionals only